Form 4: Hims & Hers Health PAO Irene Becklund Reports Stock Sale and RSU Grant
SEC Form 4 Filing
Irene Becklund, PAO of Hims & Hers Health, sold 2,747 shares of Class A Common Stock and was granted 69,518 Restricted Stock Units (RSUs).
Summary
- On March 7, 2024, Irene Becklund, the PAO of Hims & Hers Health, Inc., sold 2,747 shares of Class A Common Stock at a price of $14.19 per share.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 11, 2023.
- On March 5, 2024, Becklund was granted 69,518 Restricted Stock Units (RSUs) which represent a contingent right to receive one share of Class A Common Stock for each RSU.
- The RSUs vest in substantially equal quarterly installments over a 4-year period, starting June 15, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment.
Positives
- The Rule 10b5-1 trading plan allows insiders to sell shares without being accused of trading on inside information.
Future Outlook
The reporting person will continue to receive quarterly vesting of RSUs over the next four years.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The stock sale by an insider could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
- The RSU grant aligns the interests of the reporting person with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| September 11, 2023 | Date of adoption of Rule 10b5-1 trading plan |
| March 05, 2024 | Date of RSU grant |
| March 07, 2024 | Date of stock sale |
| June 15, 2024 | First vesting date for RSUs |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.